Firefly Neuroscience, Inc. (AIFF)
Automate Your Wheel Strategy on AIFF
With Tiblio's Option Bot, you can configure your own wheel strategy including AIFF - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AIFF
- Rev/Share 0.0338
- Book/Share 0.9551
- PB 2.6908
- Debt/Equity 0.0
- CurrentRatio 2.6945
- ROIC -0.8673
- MktCap 34410090.0
- FreeCF/Share -0.8671
- PFCF -3.1324
- PE -1.4257
- Debt/Assets 0.0
- DivYield 0
- ROE -4.6403
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 2
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research
Published: July 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
– Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs – – Collaboration aims to uncover novel insights into the brain's functional architecture in rare genetic conditions – – Building and growing a license business is an increasingly important pillar of Firefly's commercial strategy – KENMORE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to highlight its ongoing collaboration with Prof.
Read More
Firefly Neuroscience to be Added to the Russell Microcap® Index
Published: June 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap® Index as part of this year's reconstitution.
Read More
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Published: May 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows:
Read More
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
Extends cash runway well into mid-2026; no new/replacement warrants issued Extends cash runway well into mid-2026; no new/replacement warrants issued
Read More
Firefly Neuroscience Accepted into NVIDIA Connect Program
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform
Read More
About Firefly Neuroscience, Inc. (AIFF)
- IPO Date 2002-11-28
- Website https://fireflyneuro.com
- Industry Software - Application
- CEO Greg Lipschitz
- Employees 13